Japan Tissue Engineering Co., Ltd.
JPX: 7774.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kazuto Yamada
- Employees
- 211
- Headquarters
- Gamagori, Japan
- IPO year
- 2007
- Market cap
- ¥23.9B
- Website
- https://www.jpte.co.jp
Loading 7774…
Loading profile data…Frequently asked questions about 7774
What does Japan Tissue Engineering Co., Ltd. (7774.T) do?
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical ins...
Where does 7774.T trade?
Japan Tissue Engineering Co., Ltd. (7774.T) trades on the Tokyo Stock Exchange.
What sector is 7774.T in?
Japan Tissue Engineering Co., Ltd. (7774.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Japan Tissue Engineering Co., Ltd.?
Kazuto Yamada is the chief executive officer of Japan Tissue Engineering Co., Ltd. (7774.T).
Where is Japan Tissue Engineering Co., Ltd. headquartered?
Japan Tissue Engineering Co., Ltd. is headquartered in Japan.
Does 7774.T pay a dividend?
Japan Tissue Engineering Co., Ltd. (7774.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 7774.T go public?
Japan Tissue Engineering Co., Ltd. (7774.T) completed its initial public offering in 2007.